- Home
- STAA vs CLVT Comparison
STAA vs CLVT Comparison
Compare STAA & CLVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STAA | CLVT |
|---|---|---|
| Founded | 1982 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | STAA | CLVT |
|---|---|---|
| Price | $20.38 | $1.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $22.81 | $3.22 |
| AVG Volume (30 Days) | 764.5K | ★ 3.9M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | ★ 0.26 | N/A |
| Revenue | $239,442,000.00 | ★ $974,345,000.00 |
| Revenue This Year | $30.82 | N/A |
| Revenue Next Year | $8.41 | $2.12 |
| P/E Ratio | $79.42 | ★ N/A |
| Revenue Growth | N/A | ★ 0.61 |
| 52 Week Low | $15.59 | $1.66 |
| 52 Week High | $35.87 | $3.96 |
Technical Indicators
Market Signals| Indicator | STAA | CLVT |
|---|---|---|
| Relative Strength Index (RSI) | 33.60 | 43.52 |
| Support Level | $19.82 | $1.79 |
| Resistance Level | $26.21 | $2.07 |
| Average True Range (ATR) | 0.92 | 0.10 |
| MACD | -0.21 | -0.00 |
| Stochastic Oscillator | 12.07 | 12.50 |
Price Performance
Historical ComparisonAbout STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.